More quotes on testing capacity.
US commercial labs won’t be able to cope with a testing surge during flu season, Quest executive warns
From CNN’s Health Gisela Crespo
US labs won’t be able to cope with a surge in demand for Covid-19 tests in the fall during flu season, and time lags to process the tests will likely worsen, James Davis, an executive vice president at Quest Diagnostics, told the Financial Times.
In an interview published Tuesday, Davis said, “There is no way that PCR capacity is going to double in the next three months,” referring to the polymerase chain reaction (PCR) tests – the most common and most accurate tests for determining whether someone is currently infected with coronavirus.
Where testing stands now: Quest said in a Monday news release Covid-19 test results are lagging by up to two weeks in some cases, as the company works to handle the increased load from surging cases. The average turnaround time for test results in priority patients is now more than two days compared to one day a week ago, the lab said.
The shortage of chemical reagents and testing machines is what is keeping Quest from being able to expand its testing capacities, Davis told FT. The Quest executive called for academic institutions and the industry to find other solutions to resolve testing problems. He added that pool testing and a blood test that detects a type of antibody early in the infection could help.
The US Food and Drug Administration on Saturday granted an Emergency Use Authorization (EUA) for Quest to conduct pool testing for Covid-19.
Meanwhile, LabCorp, another prominent diagnostic company, said in a news release Sunday that it is processing 165,000 coronavirus tests per day and is delivering results between 3-5 days from specimen pickup.
Speaking on CNBC’s Closing Bell Tuesday, LabCorp CEO Adam Schechter said he is also concerned about the fall, when students go back to school, and called on states to do everything they can to control the spread of the virus.
“We’re continuing to increase capacity every single week over week,” Schechter told CNBC. “The problem is that the number of tests being asked to be performed each week is growing faster than the capacity that we can build.”